Insider · CIK 0001355537

Polymeropoulos Mihael Hristos

CIK 0001355537 Name as filed on the most recent filing

Filed as Polymeropoulos Mihael Hristos (51)

147 transaction lines · from 51 filings · filed 2006-11-08 to 2026-03-04 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

147 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2015-09-09 S, Open-market sale Vanda Pharmaceuticals Inc.VNDA 369,985, disposed Open Form 4 filing 0001209191-15-070343
2015-05-22 S, Open-market sale Vanda Pharmaceuticals Inc.VNDA 1,754,050, disposed Open Form 4 filing 0001209191-15-046933
2015-05-21 S, Open-market sale Vanda Pharmaceuticals Inc.VNDA 177,287, disposed Open Form 4 filing 0001209191-15-046933
2015-03-10 S, Open-market sale Vanda Pharmaceuticals Inc.VNDA 230,607, disposed Open Form 4 filing 0001209191-15-025772
2013-11-19 S, Open-market sale Vanda Pharmaceuticals Inc.VNDA 107,784, disposed Open Form 4 filing 0001209191-13-053648
2012-02-16 S, Open-market sale Vanda Pharmaceuticals Inc.VNDA 53,254, disposed Open Form 4 filing 0001209191-12-011833
2011-08-23 P, Open-market purchase Vanda Pharmaceuticals Inc.VNDA 42,353, acquired Open Form 4 filing 0001209191-12-009621
2011-08-23 P, Open-market purchase Vanda Pharmaceuticals Inc.VNDA 42,353, acquired Open Form 4 filing 0001209191-11-045483
2011-08-22 P, Open-market purchase Vanda Pharmaceuticals Inc.VNDA 11,112, acquired Open Form 4 filing 0001209191-12-009621
2011-08-22 P, Open-market purchase Vanda Pharmaceuticals Inc.VNDA 11,112, acquired Open Form 4 filing 0001209191-11-045483
2010-12-10 S, Open-market sale Vanda Pharmaceuticals Inc.VNDA 669,176, disposed Open Form 4 filing 0001209191-10-059974
2010-12-09 S, Open-market sale Vanda Pharmaceuticals Inc.VNDA 141,100, disposed Open Form 4 filing 0001209191-10-059974
2008-08-20 P, Open-market purchase Vanda Pharmaceuticals Inc.VNDA 4 lines 56,746, acquired Open Form 4 filing 0001209191-08-048668
2008-08-11 P, Open-market purchase Vanda Pharmaceuticals Inc.VNDA 4 lines 134,917, acquired Open Form 4 filing 0001209191-08-046645
2008-08-07 P, Open-market purchase Vanda Pharmaceuticals Inc.VNDA 2 lines 182,372, acquired Open Form 4 filing 0001209191-08-046460
2007-08-13 S, Open-market sale Vanda Pharmaceuticals Inc.VNDA 162,300, disposed Open Form 4 filing 0001209191-07-048477
2007-07-16 S, Open-market sale Vanda Pharmaceuticals Inc.VNDA 209,600, disposed Open Form 4 filing 0001209191-07-042872
2007-06-11 S, Open-market sale Vanda Pharmaceuticals Inc.VNDA 14 lines 207,335, disposed Open Form 4 filing 0001209191-07-042864
2007-06-11 S, Open-market sale Vanda Pharmaceuticals Inc.VNDA 105,570, disposed Open Form 4 filing 0001209191-07-036650
2007-06-11 S, Open-market sale Vanda Pharmaceuticals Inc.VNDA 24,523, disposed Open Form 4 filing 0001209191-07-036650
2007-06-11 S, Open-market sale Vanda Pharmaceuticals Inc.VNDA 14,497, disposed Open Form 4 filing 0001209191-07-036650
2007-06-11 S, Open-market sale Vanda Pharmaceuticals Inc.VNDA 12,836, disposed Open Form 4 filing 0001209191-07-036650
2007-06-11 S, Open-market sale Vanda Pharmaceuticals Inc.VNDA 12,438, disposed Open Form 4 filing 0001209191-07-036650
2007-06-11 S, Open-market sale Vanda Pharmaceuticals Inc.VNDA 8,352, disposed Open Form 4 filing 0001209191-07-036650
2007-06-11 S, Open-market sale Vanda Pharmaceuticals Inc.VNDA 8,328, disposed Open Form 4 filing 0001209191-07-036650
2007-06-11 S, Open-market sale Vanda Pharmaceuticals Inc.VNDA 6,261, disposed Open Form 4 filing 0001209191-07-036650
2007-06-11 S, Open-market sale Vanda Pharmaceuticals Inc.VNDA 4,136, disposed Open Form 4 filing 0001209191-07-036650
2007-06-11 S, Open-market sale Vanda Pharmaceuticals Inc.VNDA 2,086, disposed Open Form 4 filing 0001209191-07-036650
2007-06-11 S, Open-market sale Vanda Pharmaceuticals Inc.VNDA 2,085, disposed Open Form 4 filing 0001209191-07-036650
2007-06-11 S, Open-market sale Vanda Pharmaceuticals Inc.VNDA 2,076, disposed Open Form 4 filing 0001209191-07-036650

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 28
  • Open-market sale 119
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Polymeropoulos Mihael Hristos, insider transactions. Retrieved 2026-08-23 from https://ebomi.com/insider/0001355537

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.